The policy would have carried steep costs, putting taxpayers on the hook for an estimated $40 billion in additional spending over a decade
Clinically, semaglutide 2.4 mg not only helps weight loss but also improves cardiovascular risk factors (blood pressure, lipids) and physical function in patients with obesity
no regulatory body Health Canada, the FDA, the EMA, the TGA, or any equivalent has approved the compound as a drug for human or veterinary use
A high-quality compounded option may not satisfy someone expecting FDA clinical trial data
We therefore highlight the need to further investigate non-invasively accessible biological fluids, especially locally accessible such as menstrual fluid or cervical mucus
Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863